Rare diseases
Investigational molecules
Locations
Study on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
SpainStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
SpainStudy to Compare Weekly Islatravir/Lenacapavir with Bictegravir/Emtricitabine/Tenofovir in People with HIV-1 Who Are Virologically Suppressed
SpainStudy on the Effects of Mosliciguat for Patients with Pulmonary Hypertension Linked to Interstitial Lung Disease
SpainStudy on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
SpainStudy on the Effects of Abiprubart for Patients with Sjögren’s Disease
SpainStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
SpainStudy of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate
SpainStudy on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis
SpainStudy Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma
SpainLong-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)
SpainStudy on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
